| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.605 | 5.585 | 4.452 | 6.007 | 6.431 | 7.086 | 14.768 | 20.014 | 23.586 |
| Total Income - EUR | - | 1.605 | 5.585 | 4.560 | 6.007 | 6.638 | 7.086 | 14.769 | 20.383 | 23.586 |
| Total Expenses - EUR | - | 146 | 68 | 332 | 0 | 3.657 | 3.573 | 8.499 | 14.321 | 22.384 |
| Gross Profit/Loss - EUR | - | 1.459 | 5.518 | 4.227 | 6.007 | 2.981 | 3.513 | 6.269 | 6.062 | 1.202 |
| Net Profit/Loss - EUR | - | 1.411 | 5.350 | 4.094 | 5.827 | 2.788 | 3.348 | 5.996 | 5.862 | 579 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Novalog Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.556 |
| Current Assets | - | 449 | 5.841 | 10.164 | 15.974 | 18.642 | 21.485 | 27.836 | 7.162 | 1.420 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 407 |
| Cash | - | 449 | 5.841 | 10.164 | 15.974 | 18.642 | 21.485 | 27.836 | 7.162 | 1.013 |
| Shareholders Funds | - | 436 | 5.779 | 9.767 | 15.404 | 17.900 | 20.851 | 26.912 | 5.911 | 6.457 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 13 | 62 | 397 | 570 | 742 | 634 | 924 | 1.251 | 13.796 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Novalog Medical Srl